Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

BACKGROUND: This study evaluated the effect of empagliflozin on postprandial glucose (PPG) and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus (T2DM). METHODS: Patients (N = 60; baseline mean [SD] HbA1c 7.91 [0.80]%; body mass index 24.3 [3.2] kg/m(2)) were randomized...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Diabetol
Auteurs principaux: Nishimura, Rimei, Tanaka, Yuko, Koiwai, Kazuki, Inoue, Kohei, Hach, Thomas, Salsali, Afshin, Lund, Søren S, Broedl, Uli C
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4339254/
https://ncbi.nlm.nih.gov/pubmed/25633683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-014-0169-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires